Loading clinical trials...
Loading clinical trials...
RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS
Conditions
Interventions
bleomycin sulfate
filgrastim
+9 more
Locations
153
United States
Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
Arizona Cancer Center
Tucson, Arizona, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
City of Hope Comprehensive Cancer Center
Duarte, California, United States
Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
Rebecca and John Moores UCSD Cancer Center
La Jolla, California, United States
Start Date
September 1, 1994
Completion Date
July 1, 2006
Last Updated
June 26, 2013
NCT07453082
NCT05670938
NCT06191575
NCT00104676
NCT05012397
NCT00716976
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions